title: The influence of low molecular weight heparin on neointimal proliferation in cultured human saphenous vein.
abstract: OBJECTIVE
  To investigate the effect of low molecular weight heparin (LMWH) on neointimal proliferation in cultured human saphenous vein, a model of human vein graft intimal hyperplasia.
  
  
  METHODS
  Dose ranging LMWH concentration study.
  
  
  METHODS
  Culture Laboratory, Department of Surgery.
  
  
  METHODS
  Fifteen segments of human long saphenous vein were incubated at 37 degrees C for 14 days in culture medium with 30% foetal calf serum. LMWH was added to one of the paired segments at 1, 10 and 100 micrograms/ml (five veins each dose). 5-bromo-2-deoxyuridine (Brd-U) was used to label proliferating cells.
  
  
  METHODS
  Neointimal thickness (micron and proliferation index (% labelled neointimal cells).
  
  
  RESULTS
  Neointimal thickness and proliferation index were both significantly reduced by LMWH at 100 micrograms/ml [control vs. LMWH, reduction in thickness 21 microns vs. 7 microns (median difference 12 microns, 95% conf. int. 6-18), reduction in proliferation index 33% to 6% (median difference 19%, 95% C.I. 4-32)].
  
  
  CONCLUSIONS
  High dose LMWH reduces neointimal proliferation in cultured human saphenous vein. The practical clinical application of these results may require the use of non anticoagulant heparin-like molecules and/or local drug delivery systems.
authors.affiliation: Department of Surgery, University of Leicester, U.K.
authors.forename: K
authors.initials: K
authors.lastname: Varty
authors.forename: K E
authors.initials: KE
authors.lastname: Allen
authors.forename: L
authors.initials: L
authors.lastname: Jones
authors.forename: R D
authors.initials: RD
authors.lastname: Sayers
authors.forename: D A
authors.initials: DA
authors.lastname: Ratliff
authors.forename: P R
authors.initials: PR
authors.lastname: Bell
authors.forename: N J
authors.initials: NJ
authors.lastname: London
mesh_terms: D002455:Cell Division / Q000187:drug effects; D006495:Heparin, Low-Molecular-Weight / Q000494:pharmacology*; D006801:Humans; D006965:Hyperplasia / Q000517:prevention & control; D009924:Organ Culture Techniques; D012501:Saphenous Vein / Q000187:drug effects* / Q000473:pathology; D017539:Tunica Intima / Q000187:drug effects* / Q000473:pathology
chemical_list: D006495:Heparin, Low-Molecular-Weight